-
Lyso-Tracker Red for Nanoparticle Trafficking
2026-08-19
Lyso-Tracker Red converts lysosomal acidification into a live-cell readout for tracking how CLam/OVA vaccine nanoparticles move through antigen-presenting cells. This practical workflow distinguishes uptake, acidic-compartment residence, and apparent lysosomal escape while highlighting controls, imaging choices, and troubleshooting limits.
-
TH287 MTH1 Inhibitor: Mechanism & Evidence
2026-08-18
TH287 is a potent MTH1 inhibitor that disrupts oxidized-nucleotide sanitation and promotes DNA damage in cancer research models. Product data report an IC50 of 0.8 ± 0.1 nM, while a 2026 in vitro study found schedule-sensitive radiosensitization of castration-resistant prostate cancer cells.
-
Ziprasidone HCl: From Receptor Biology to Oncology
2026-08-18
Ziprasidone HCl offers translational researchers a rare opportunity to study receptor pharmacology, glutamine metabolism, and formulation-dependent exposure within one experimental framework. This thought-leadership guide connects mechanistic evidence with assay design, permeability strategy, and the practical limits of moving from neuroscience research to oncology.
-
Autophagy, Resveratrol, and Apoptosis in RCC
2026-08-17
Yao, Fan, and He showed that resveratrol induces ROS-associated mitochondrial damage and caspase-3-dependent apoptosis in renal cell carcinoma 786-O cells, while simultaneously activating JNK-linked autophagy. The study’s central implication is that autophagy functions as a protective response, making combined resveratrol and autophagy inhibition a mechanistically rational strategy for further investigation.
-
Acetoacetic acid sodium salt in metabolic workflows
2026-08-17
Acetoacetic acid sodium salt provides a water-compatible way to model ketone-body exposure, fatty acid catabolism, and diabetes-associated metabolic imbalance. This guide combines practical dosing, sample handling, analytical controls, and isotope-standard lessons from a separate synthesis study to improve reproducibility.
-
Novel Allosteric PDK4 Inhibitors: Evidence from 8c
2026-08-16
The 2019 Journal of Medicinal Chemistry study identified anthraquinone-derived allosteric inhibitors of pyruvate dehydrogenase kinase 4, with compound 8c showing 84 nM biochemical potency and activity in metabolic, allergic, and cancer-related preclinical models. Its integrated medicinal chemistry, pharmacokinetic, animal, cellular, and docking data support PDK4 as a tractable target while also defining important limits for translation beyond the reported models.
-
ABT-263 (Navitoclax): Reliable Apoptosis Assays
2026-08-15
A scenario-based guide to using ABT-263 (Navitoclax), SKU A3007, for reproducible apoptosis, viability, and cytotoxicity workflows. It connects Bcl-2-family biology with practical solvent handling, assay design, orthogonal validation, and evidence-based product selection.
-
RCN2 Drives ESCC Metastasis and Cisplatin Resistance
2026-08-14
The reference study identifies RCN2 as a driver of esophageal squamous cell carcinoma metastasis and cisplatin resistance through UBR5-dependent ubiquitination and degradation of PPP2CA. Its integrated molecular, biochemical, clinical, and animal-model evidence places the RCN2–PPP2CA–PI3K-AKT axis at the center of an experimentally testable resistance mechanism.
-
Reserpine (N1867): Workflow Guide
2026-08-14
This guide explains how to qualify, dissolve, store, and control Reserpine (SKU N1867) for neurotransmitter depletion research, antihypertensive mechanism studies, and neuropharmacology research. It is intended for controlled laboratory use only and does not provide clinical, diagnostic, therapeutic, or veterinary guidance.
-
Proteinase K: Selectivity in DNA and Protease Assays
2026-08-13
Proteinase K is more than a routine digestion reagent: its stability, substrate preference, and inhibitor profile make it a powerful tool for genomic DNA isolation and assay control. This article connects DNA purification practice with a SARS-CoV-2 protease-screening study to clarify when broad proteolysis improves, rather than obscures, experimental interpretation.
-
HyperFluor 488 Goat Anti-Rabbit IgG Guide
2026-08-13
HyperFluor™ 488 Goat Anti-Rabbit IgG (H+L) Antibody provides fluorescent detection of rabbit primary antibodies in immunofluorescence, microscopy, flow cytometry, and related assays. It should not be used as a standalone antigen-binding reagent, with non-rabbit primary antibodies, or in workflows incompatible with sodium azide or fluorescent detection.
-
Boc-D-FMK Workflows for Apoptosis Research
2026-08-12
Boc-D-FMK provides a practical way to suppress activated caspases while monitoring linked inflammatory signaling in cell and animal models. This guide connects apoptosis-focused workflows with renal endothelial, hepatocyte, and hypothesis-generating liver fibrosis applications, while emphasizing formulation, timing, controls, and interpretation limits.
-
Wnt–BMP Patterning in Hemichordate Neuroectoderm
2026-08-12
Le Petillon and colleagues show that Wnt and BMP signals have distinct, temporally changing roles in patterning the anterior neuroectoderm of the indirect-developing hemichordate Ptychodera flava. The study links posterior Wnt activity to anterior restriction and identifies a biphasic BMP contribution to neuroectoderm formation and regeneration, refining models of deuterostome developmental conservation.
-
Kupffer Cell Plasticity in Liver Metastasis
2026-08-11
The reference study shows that liver metastasis-associated macrophages are sustained not only by recruited monocytes but also by local macrophage proliferation and infiltration of reprogrammed Kupffer cells. Its lineage-tracing, depletion, proliferation-recording, flow-cytometry, immunofluorescence, and CITE-seq strategy provides a framework for distinguishing macrophage origin from macrophage state in metastatic liver tissue.
-
Ceruletide Workflows for Pancreatic Fibrosis
2026-08-10
Ceruletide, also called Caerulein in pancreatic injury models, provides a defined CCK-receptor stimulus for pancreatic secretion, fibrosis, and gastrointestinal motility experiments. This practical guide connects dose planning, peptide handling, and orthogonal autophagy assays to the ORM2–ZG16 findings in chronic pancreatitis research.